1. Home
  2. CTKB vs PUBM Comparison

CTKB vs PUBM Comparison

Compare CTKB & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • PUBM
  • Stock Information
  • Founded
  • CTKB 1990
  • PUBM 2006
  • Country
  • CTKB United States
  • PUBM United States
  • Employees
  • CTKB N/A
  • PUBM N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PUBM Computer Software: Prepackaged Software
  • Sector
  • CTKB Health Care
  • PUBM Technology
  • Exchange
  • CTKB Nasdaq
  • PUBM Nasdaq
  • Market Cap
  • CTKB 433.8M
  • PUBM 406.5M
  • IPO Year
  • CTKB 2021
  • PUBM 2020
  • Fundamental
  • Price
  • CTKB $5.58
  • PUBM $8.71
  • Analyst Decision
  • CTKB Hold
  • PUBM Buy
  • Analyst Count
  • CTKB 4
  • PUBM 11
  • Target Price
  • CTKB $5.88
  • PUBM $18.50
  • AVG Volume (30 Days)
  • CTKB 1.6M
  • PUBM 1.1M
  • Earning Date
  • CTKB 11-05-2025
  • PUBM 11-10-2025
  • Dividend Yield
  • CTKB N/A
  • PUBM N/A
  • EPS Growth
  • CTKB N/A
  • PUBM N/A
  • EPS
  • CTKB N/A
  • PUBM N/A
  • Revenue
  • CTKB $196,828,000.00
  • PUBM $288,382,000.00
  • Revenue This Year
  • CTKB N/A
  • PUBM N/A
  • Revenue Next Year
  • CTKB $7.25
  • PUBM $1.40
  • P/E Ratio
  • CTKB N/A
  • PUBM N/A
  • Revenue Growth
  • CTKB N/A
  • PUBM N/A
  • 52 Week Low
  • CTKB $2.37
  • PUBM $7.01
  • 52 Week High
  • CTKB $7.30
  • PUBM $17.32
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 71.13
  • PUBM 49.86
  • Support Level
  • CTKB $5.10
  • PUBM $8.57
  • Resistance Level
  • CTKB $6.18
  • PUBM $9.64
  • Average True Range (ATR)
  • CTKB 0.43
  • PUBM 0.60
  • MACD
  • CTKB 0.09
  • PUBM 0.01
  • Stochastic Oscillator
  • CTKB 75.21
  • PUBM 39.75

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About PUBM PubMatic Inc.

PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.

Share on Social Networks: